Skip to main content

Advertisement

ADVERTISEMENT

News

News
01/12/2024

CardioFocus Press Release 

CardioFocus Press Release 
Acquisition includes CE- Marked CENTAURI™ Pulsed Field system Accelerates CardioFocus' development of the HeartLight X4 true single shot pulse field ablation catheter
Acquisition includes CE- Marked CENTAURI™ Pulsed Field system Accelerates CardioFocus' development of the HeartLight X4 true single shot pulse field ablation catheter
Acquisition includes CE- Marked...
01/12/2024
EP Lab Digest
News
01/11/2024

Modular Devices Press Release 

Modular Devices Press Release  ...
Indianapolis, IN, January 1, 2024 — Modular Devices, a nationwide leader in mobile imaging and cleanroom solutions, announces a pivotal leadership transition as Greg Mink steps down as CEO, passing the baton to Mark Koers, effective January...
Indianapolis, IN, January 1, 2024 — Modular Devices, a nationwide leader in mobile imaging and cleanroom solutions, announces a pivotal leadership transition as Greg Mink steps down as CEO, passing the baton to Mark Koers, effective January...
Indianapolis, IN, January 1,...
01/11/2024
EP Lab Digest
News
01/09/2024

Orchestra BioMed Press Release 

Orchestra BioMed Press Release  ...
Orchestra BioMed and Medtronic, Inc., have an exclusive strategic collaboration for development and commercialization of AVIM therapy for hypertensive pacemaker population, which is estimated to be more than 750,000 patients annually worldwide
Orchestra BioMed and Medtronic, Inc., have an exclusive strategic collaboration for development and commercialization of AVIM therapy for hypertensive pacemaker population, which is estimated to be more than 750,000 patients annually worldwide
Orchestra BioMed and Medtronic,...
01/09/2024
EP Lab Digest

Advertisement

News
01/08/2024

Stereotaxis Press Release 

Stereotaxis Press Release 
St. Louis, Jan. 8, 2024 – Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced that the first patients have been successfully treated using its Magnetic Interventional...
St. Louis, Jan. 8, 2024 – Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced that the first patients have been successfully treated using its Magnetic Interventional...
St. Louis, Jan. 8, 2024 –...
01/08/2024
EP Lab Digest
News
01/05/2024

Medtronic Press Release

Medtronic Press Release
New pacemakers offer 40% more battery life,1 extend Medtronic legacy of pacing leadership DUBLIN, Jan. 5, 2024/ -- Medtronic plc, a global leader in healthcare technology, today announced it has received CE (Conformité Européenne)...
New pacemakers offer 40% more battery life,1 extend Medtronic legacy of pacing leadership DUBLIN, Jan. 5, 2024/ -- Medtronic plc, a global leader in healthcare technology, today announced it has received CE (Conformité Européenne)...
New pacemakers offer 40% more...
01/05/2024
EP Lab Digest
News
01/05/2024

Kestra Medical Technologies Press Release

Kestra Medical Technologies Press Rel...
Additional Health Plans Contract with Kestra Medical Technology Services, Inc., increasing patient access to the ASSURE system as a covered service.
Additional Health Plans Contract with Kestra Medical Technology Services, Inc., increasing patient access to the ASSURE system as a covered service.
Additional Health Plans Contract...
01/05/2024
EP Lab Digest

Advertisement

News
01/03/2024

iRhythm Press Release 

iRhythm Press Release 
CE mark reinforces the Zio monitor system as a leading innovation in ambulatory cardiac monitoring and highlights the company’s commitment to providing the highest quality product and services globally
CE mark reinforces the Zio monitor system as a leading innovation in ambulatory cardiac monitoring and highlights the company’s commitment to providing the highest quality product and services globally
CE mark reinforces the Zio...
01/03/2024
EP Lab Digest
News
01/03/2024

Pulse Biosciences Press Release 

Pulse Biosciences Press Release  ...
HAYWARD, Calif.-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, today announced...
HAYWARD, Calif.-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, today announced...
HAYWARD, Calif.-- Pulse...
01/03/2024
EP Lab Digest
News
01/03/2024

Cytokinetics Press Release 

Cytokinetics Press Release 
SOUTH SAN FRANCISCO, Calif., Dec. 27, 2023 -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced positive topline results from SEQUOIA-HCM (Safety, Efficacy, and Quantitative Understanding of Obstruction Impact of Aficamten in HCM),...
SOUTH SAN FRANCISCO, Calif., Dec. 27, 2023 -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced positive topline results from SEQUOIA-HCM (Safety, Efficacy, and Quantitative Understanding of Obstruction Impact of Aficamten in HCM),...
SOUTH SAN FRANCISCO, Calif.,...
01/03/2024
EP Lab Digest

Advertisement

News
01/02/2024

Boston Scientific Press Release 

Boston Scientific Press Release  ...
MARLBOROUGH, Mass., Dec. 28, 2023 -- Boston Scientific Corporation (NYSE: BSX) has initiated the AVANT GUARD clinical trial to evaluate the safety and effectiveness of the FARAPULSE™ Pulsed Field Ablation (PFA) System* as a first-line...
MARLBOROUGH, Mass., Dec. 28, 2023 -- Boston Scientific Corporation (NYSE: BSX) has initiated the AVANT GUARD clinical trial to evaluate the safety and effectiveness of the FARAPULSE™ Pulsed Field Ablation (PFA) System* as a first-line...
MARLBOROUGH, Mass., Dec. 28,...
01/02/2024
EP Lab Digest

Advertisement